Max Healthcare raises Rs 1,200 crore via QIP issue route
New Delhi: Max Healthcare Institute Ltd (MHC) on Wednesday said it has raised Rs 1,200 crore via issue of securities. The company, which is the country's second largest private hospital chain, has raised the capital through qualified institutional placement (QIP).
The QIP opened on March 4, 2021, and closed on March 9, 2021.
The healthcare major has accordingly issued 6,14,12,482 fresh equity shares of face value of Rs 10 per share at a price of Rs 195.40 per share, MHC said in a statement.
Post the QIP, the issued and subscribed equity share capital of MHC stands at 96,59,45,006 equity shares, it added.
MHC proposes to utilise the net proceeds for meeting the capital expenditure and working capital requirements, including expansion of capacity, increasing stake in existing/future subsidiaries etc, it said.
The company may also use part of the proceeds for repayment of debt and for general corporate requirements or any other purposes as maybe permissible, it added.
"We would like to thank investors for their overwhelming response towards our QIP. With this, we have fortified our balance sheet to tap growth opportunities and also strengthened our investor base with blue chip domestic mutual funds and global long only funds," Max Healthcare Chairman and Managing Director Abhay Soi said.
MHC will continue to provide high-end medical care for patients by investing in cutting-edge clinical technologies, infrastructure, clinical and management talent, he added.
Pursuant to this issue, the public shareholding of MHC stands at 29.54 per cent.
However, this includes 4.82 per cent which is not currently considered for compliance towards minimum public shareholding threshold under Sebi regulations for listed companies.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.